Halozyme Therapeutics
HALO
#1820
Rank
NZ$20.27 B
Marketcap
NZ$178.64
Share price
1.83%
Change (1 day)
52.78%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): NZ$0.85 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.50 Billion. In 2025 the company made an earning of NZ$0.79 Billion a decrease over its 2024 earnings that were of NZ$0.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.85 B7.32%
2025 NZ$0.79 B-16.2%
2024 NZ$0.94 B59.94%
2023 NZ$0.59 B39.94%
2022 NZ$0.42 B0.16%
2021 NZ$0.42 B92.2%
2020 NZ$0.22 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.14 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.18 Billion216.03%
2015 -NZ$54.9 Million-52.86%
2014 -NZ$0.12 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$91.21 Million169.94%
2011 -NZ$33.79 Million-63.44%
2010 -NZ$92.41 Million-7.19%
2009 -NZ$99.57 Million15.91%
2008 -NZ$85.9 Million83.89%
2007 -NZ$46.72 Million78.1%
2006 -NZ$26.23 Million16%
2005 -NZ$22.61 Million45.24%
2004 -NZ$15.57 Million682.42%
2003 -NZ$1.99 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.24 B 5,060.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.03 B 2,004.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.00 B 6,083.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.04 B 1,421.43%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-NZ$0.87 Billion-200.92%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$48.67 Million-105.68%๐Ÿ‡บ๐Ÿ‡ธ USA